Literature DB >> 11162897

Identification and characterization of two androgen response regions in the human neutral endopeptidase gene.

R Shen1, M Sumitomo, J Dai, D O Hardy, D Navarro, B Usmani, C N Papandreou, L B Hersh, M A Shipp, L P Freedman, D M Nanus.   

Abstract

Transcription of the human neutral endopeptidase 24.11 (NEP) gene is androgen regulated in prostate cancer cells. Homology search identified a sequence GTCACAaagAGTTCT similar to the ARE consensus sequence GGTACAnnnTGTTCT within the 3'-untranslated region of the NEP mRNA. A double-stranded radiolabelled oligonucleotide containing this NEP-ARE sequence formed a DNA-protein complex with nuclear proteins from LNCaP cells or COS-7 cells co-transfected with an androgen receptor (AR) expression vector, and with full-length AR synthesized by baculovirus in mobility shift assays. Unlabeled NEP-ARE or consensus ARE but not mutated NEP-ARE replaced radiolabelled NEP-ARE. Steroid-dependent enhancement of transcription was assayed by transfecting ptkCAT reporter constructs containing the NEP-ARE into CV-1/AR cells and prostate cancer cells (PC-3/AR). Enhancement of chloramphenicol acetyltransferase (CAT) activity was increased four-fold by androgen, seven-fold by dexamethasone and three-fold by progesterone in CV-1/AR cells, and the NEP-ARE bound to glucocorticoid and progesterone receptor in mobility shift assays. We next performed DNase-I footprinting analysis of the NEP promoter and identified a 23 bp sequence GGTGCGGGTCGGAGGGATGCCCA (NEP-ARR) which was protected from DNase I cleavage by nuclear extracts from COS-7 cells expressing AR. This sequence was 62.5% homologous to an androgen responsive region (PSA-ARR) identified in the promoter of the prostate specific antigen (PSA) gene. A double-stranded radiolabelled oligonucleotide containing this NEP-ARR sequence formed DNA-protein complex with AR but not GR proteins. Unlabeled NEP-ARR, PSA-ARR and NEP-ARE replaced radiolabelled NEP-ARR. Steroid-dependent enhancement of transcription assays in PC-3/AR cells revealed that the enhancement of CAT activity was increased 2.3-fold by androgen, but not by glucocorticoid or progesterone. In a thymidine kinase promoter, the NEP-ARE and NEP-ARR together stimulated a five-fold increase in promoter activity in PC cells. These data suggest that steroid regulation of the NEP gene involves at least two elements including a typical ARE which binds androgen, progesterone and glucocorticoid receptors, and a unique ARR which only binds androgen receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11162897     DOI: 10.1016/s0303-7207(00)00326-9

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  19 in total

1.  Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids.

Authors:  Tina R Hubler; Jonathan G Scammell
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

2.  Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells.

Authors:  D M Altintas; M S Shukla; D Goutte-Gattat; D Angelov; J P Rouault; S Dimitrov; Jacques Samarut
Journal:  Mol Endocrinol       Date:  2012-07-06

3.  Genetic targeting aromatase in male amyloid precursor protein transgenic mice down-regulates beta-secretase (BACE1) and prevents Alzheimer-like pathology and cognitive impairment.

Authors:  Carrie McAllister; Jiangang Long; Adrienne Bowers; Aaron Walker; Philip Cao; Shin-Ichiro Honda; Nobuhiro Harada; Matthias Staufenbiel; Yong Shen; Rena Li
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

4.  Altered NEP2 expression and activity in mild cognitive impairment and Alzheimer's disease.

Authors:  Jeffrey Y Huang; Daniel M Hafez; Bryan D James; David A Bennett; Robert A Marr
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

Review 5.  Protective actions of sex steroid hormones in Alzheimer's disease.

Authors:  Christian J Pike; Jenna C Carroll; Emily R Rosario; Anna M Barron
Journal:  Front Neuroendocrinol       Date:  2009-05-07       Impact factor: 8.606

6.  Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model.

Authors:  Xu Yue; Melissa Lu; Techie Lancaster; Phillip Cao; Shin-Ichiro Honda; Matthias Staufenbiel; Nobuhiro Harada; Zhenyu Zhong; Yong Shen; Rena Li
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

Review 7.  Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy.

Authors:  Natalia N Nalivaeva; Anthony J Turner
Journal:  Br J Pharmacol       Date:  2019-03-11       Impact factor: 8.739

8.  Transcriptional regulation of the mouse steroid 5alpha-reductase type II gene by progesterone in brain.

Authors:  Daisuke Matsui; Matomo Sakari; Takashi Sato; Akiko Murayama; Ichiro Takada; Misun Kim; Ken-ichi Takeyama; Shigeaki Kato
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

Review 9.  Gender, sex steroid hormones, and Alzheimer's disease.

Authors:  Rebekah S Vest; Christian J Pike
Journal:  Horm Behav       Date:  2012-04-19       Impact factor: 3.587

10.  Neutral endopeptidase is a myristoylated protein.

Authors:  Rong Zheng; Akio Horiguchi; Katsuyuki Iida; Jungoo Lee; Ruoqian Shen; Oscar B Goodman; David M Nanus
Journal:  Mol Cell Biochem       Date:  2009-09-15       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.